Tammy Kielian Selected Research

PPAR-gamma Agonists

4/2008	The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.
1/2008	Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-gamma Agonists.
9/2004	S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).
2/2003	Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tammy Kielian Research Topics

Disease

44	Infections 01/2021 - 01/2004
16	Brain Abscess (Abscess, Brain) 04/2012 - 01/2004
10	Inflammation (Inflammations) 01/2021 - 02/2003
7	Abscess 01/2019 - 10/2007
5	Persistent Infection 01/2021 - 01/2014
5	Bacterial Infections (Bacterial Infection) 12/2016 - 04/2004
4	Neoplasms (Cancer) 01/2022 - 01/2002
4	Neuroinflammatory Diseases 12/2016 - 07/2004
3	Epilepsy (Aura) 01/2021 - 04/2019
3	Disease Progression 04/2020 - 01/2014
3	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2019 - 12/2016
3	Central Nervous System Diseases (CNS Diseases) 07/2012 - 02/2003
3	Central Nervous System Infections (Central Nervous System Infection) 07/2012 - 04/2012
3	Communicable Diseases (Infectious Diseases) 01/2008 - 01/2004
2	Wounds and Injuries (Trauma) 01/2021 - 11/2013
2	Catheter-Related Infections 09/2014 - 01/2013
2	Hydrocephalus (Hydrocephaly) 01/2013 - 09/2012
2	Autoimmune Diseases (Autoimmune Disease) 07/2012 - 06/2012
2	Staphylococcal Infections 07/2011 - 01/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2009 - 10/2007
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Chronic Bronchitis 04/2020
1	Occupational Asthma 04/2020
1	Metaplasia 04/2020
1	Asthma (Bronchial Asthma) 04/2020
1	Oral Ulcer (Mouth Ulcer) 08/2019
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2019
1	Foreign Bodies (Foreign Body) 01/2019
1	Bites and Stings (Sting) 12/2016
1	Staphylococcal Pneumonia 01/2016
1	Human Influenza (Influenza) 01/2016
1	Coinfection 01/2016
1	Lung Injury 01/2016

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2020 - 01/2002
14	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 10/2007
10	ChemokinesIBA 01/2019 - 01/2004
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2007
6	Interleukin-17 (Interleukin 17)IBA 01/2013 - 11/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 01/2002
5	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2020 - 04/2006
5	Toll-Like Receptor 2IBA 04/2012 - 11/2005
4	PPAR-gamma AgonistsIBA 04/2008 - 02/2003
3	Peptides (Polypeptides)IBA 01/2019 - 01/2011
3	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2002
3	Green Fluorescent ProteinsIBA 07/2012 - 01/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2012 - 04/2004
3	LigandsIBA 06/2011 - 01/2008
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 01/2016
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 07/2011
2	Myeloid Differentiation Factor 88IBA 04/2020 - 06/2013
2	Pharmaceutical PreparationsIBA 08/2019 - 08/2004
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Caspase 1 (ICE Protease)IBA 01/2019 - 05/2014
2	InflammasomesIBA 05/2014 - 07/2012
2	Interleukin-1 (Interleukin 1)IBA 07/2012 - 04/2004
2	Glial Fibrillary Acidic ProteinIBA 07/2012 - 01/2011
2	Nitric Oxide Synthase (NO Synthase)IBA 06/2011 - 04/2008
2	ConnexinsIBA 08/2008 - 07/2004
2	Chemotactic FactorsIBA 04/2004 - 01/2002
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	AndrogensIBA 01/2022
1	ProteomeIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	Toll-Like Receptor AgonistsIBA 04/2020
1	Immunoglobulin E (IgE)IBA 04/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	bacterial fibronectin-binding proteinsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 08/2019
1	Daptomycin FDA Link 04/2019
1	HydrogelsIBA 04/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2019
1	UreaseIBA 01/2019
1	CarbonIBA 01/2019
1	AcidsIBA 01/2019
1	Pyruvic Acid (Pyruvate)IBA 01/2019
1	Glutamate DehydrogenaseIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	NitrogenIBA 01/2019
1	EnzymesIBA 01/2019
1	Amino Acids FDA Link 01/2019
1	CollagenIBA 01/2019
1	CeroidIBA 01/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 12/2016
1	Adenosine Monophosphate (AMP)IBA 12/2016
1	cyclic diadenosine phosphateIBA 12/2016
1	Interferon Type IIBA 12/2016
1	Pathogen-Associated Molecular Pattern MoleculesIBA 12/2016
1	NADP (NADPH)IBA 01/2016

Therapy/Procedure

11	Catheters 01/2021 - 06/2011
10	Therapeutics 01/2021 - 01/2002
4	Craniotomy 01/2021 - 04/2019
2	Arthroplasty 01/2018 - 01/2014
1	Neurosurgical Procedures 01/2021
1	Prostheses and Implants (Prosthesis) 01/2019
1	Treatment Delay 01/2019
1	Knee Replacement Arthroplasty (Total Knee Replacement) 02/2017